The patient was diagnosed with nongerminal-center B cell diffuse large B-cell lymphoma (DLBCL) 1 year after being diagnosed with primary biliary cholangitis (PBC).

Discover why difficult breathing might indicate heart disease, lung conditions, anxiety disorders, or blood problems, and ...

Background: Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma is a rare, indolent subtype of non-Hodgkin lymphoma ...

[1] While therapies for the treatment of dyspnea in end-stage CF lung disease are limited, case reports of its effective treatment with inhaled opioids have been published. However, the use of ...

Anyone who has visited Sydney Central Business District in the last ten days is instructed to monitor for symptoms of the ...

“Though the HR positive breast cancer treatment landscape has evolved in the last several ... occurred in 0.7% of patients due to interstitial lung disease/pneumonitis, dyspnea and sepsis. About ...

Early toxicities associated with a 3-week hypofractionated radiotherapy regimen do not raise initial safety concerns in women with breast cancer, a recent analysis finds.

Syndax has a strong cash position and a significant market opportunity with Revuforj and Niktimvo. Check out my ...

During a live event, Patrick Moore, MD, discussed the KarMMa-3 subgroup analyses and quality of life for patients with ...

Combining savolitinib with osimertinib can reverse osimertinib resistance in patients with advanced, EGFR-mutant NSCLC, data suggest.

Dupilumab improved exacerbations and lung function in patients with COPD and T2 inflammation, regardless of baseline BODE index score.

Despite solid data, the lack of high-value indications and no unique platform makes Nuvalent's valuation seem inflated; I ...